These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 28834304)

  • 1. Sofosbuvir as treatment against dengue?
    Gan CS; Lim SK; Chee CF; Yusof R; Heh CH
    Chem Biol Drug Des; 2018 Feb; 91(2):448-455. PubMed ID: 28834304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Sofosbuvir (β-D-2'-deoxy-2'-α-fluoro-2'-β-C-methyluridine) as an inhibitor of Dengue virus replication.
    Xu HT; Colby-Germinario SP; Hassounah SA; Fogarty C; Osman N; Palanisamy N; Han Y; Oliveira M; Quan Y; Wainberg MA
    Sci Rep; 2017 Jul; 7(1):6345. PubMed ID: 28740124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The search for nucleoside/nucleotide analog inhibitors of dengue virus.
    Chen YL; Yokokawa F; Shi PY
    Antiviral Res; 2015 Oct; 122():12-9. PubMed ID: 26241002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication.
    Sacramento CQ; de Melo GR; de Freitas CS; Rocha N; Hoelz LV; Miranda M; Fintelman-Rodrigues N; Marttorelli A; Ferreira AC; Barbosa-Lima G; Abrantes JL; Vieira YR; Bastos MM; de Mello Volotão E; Nunes EP; Tschoeke DA; Leomil L; Loiola EC; Trindade P; Rehen SK; Bozza FA; Bozza PT; Boechat N; Thompson FL; de Filippis AM; Brüning K; Souza TM
    Sci Rep; 2017 Jan; 7():40920. PubMed ID: 28098253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase.
    Xu HT; Colby-Germinario SP; Hassounah S; Quashie PK; Han Y; Oliveira M; Stranix BR; Wainberg MA
    Antimicrob Agents Chemother; 2016 Jan; 60(1):600-8. PubMed ID: 26574011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate selectivity of Dengue and Zika virus NS5 polymerase towards 2'-modified nucleotide analogues.
    Potisopon S; Ferron F; Fattorini V; Selisko B; Canard B
    Antiviral Res; 2017 Apr; 140():25-36. PubMed ID: 28041959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of dengue viral RNA-dependent RNA polymerase inhibitor using computational fragment-based approaches and molecular dynamics study.
    Anusuya S; Velmurugan D; Gromiha MM
    J Biomol Struct Dyn; 2016 Jul; 34(7):1512-32. PubMed ID: 26262439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Potent Non-nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from Fragment Screening and Structure-Guided Design.
    Lim SP; Noble CG; Nilar S; Shi PY; Yokokawa F
    Adv Exp Med Biol; 2018; 1062():187-198. PubMed ID: 29845534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
    Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
    BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro.
    Dragoni F; Boccuto A; Picarazzi F; Giannini A; Giammarino F; Saladini F; Mori M; Mastrangelo E; Zazzi M; Vicenti I
    Antiviral Res; 2020 Mar; 175():104708. PubMed ID: 31931104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
    Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
    Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethyl 4-(4-methylphenyl)-4-pentenoate from Vetiveria zizanioides Inhibits Dengue NS2B-NS3 Protease and Prevents Viral Assembly: A Computational Molecular Dynamics and Docking Study.
    Lavanya P; Ramaiah S; Anbarasu A
    Cell Biochem Biophys; 2016 Sep; 74(3):337-51. PubMed ID: 27324039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quercetin derivatives as non-nucleoside inhibitors for dengue polymerase: molecular docking, molecular dynamics simulation, and binding free energy calculation.
    Anusuya S; Gromiha MM
    J Biomol Struct Dyn; 2017 Oct; 35(13):2895-2909. PubMed ID: 27608509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide inhibitors against dengue virus infection.
    Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Looking for inhibitors of the dengue virus NS5 RNA-dependent RNA-polymerase using a molecular docking approach.
    Galiano V; Garcia-Valtanen P; Micol V; Encinar JA
    Drug Des Devel Ther; 2016; 10():3163-3181. PubMed ID: 27784988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship of uridine-based nucleoside phosphoramidate prodrugs for inhibition of dengue virus RNA-dependent RNA polymerase.
    Wang G; Lim SP; Chen YL; Hunziker J; Rao R; Gu F; Seh CC; Ghafar NA; Xu H; Chan K; Lin X; Saunders OL; Fenaux M; Zhong W; Shi PY; Yokokawa F
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2324-2327. PubMed ID: 29801997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
    Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.
    Smith TM; Lim SP; Yue K; Busby SA; Arora R; Seh CC; Wright SK; Nutiu R; Niyomrattanakit P; Wan KF; Beer D; Shi PY; Benson TE
    J Biomol Screen; 2015 Jan; 20(1):153-63. PubMed ID: 25252731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
    Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
    Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
    Dwivedi VD; Tripathi IP; Mishra SK
    J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.